Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Microba Life Sciences.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Probiotics supplier has gut feeling about surging growth
Health & Biotech
ScoPo’s Powerplays: ASX health stocks up in ‘fairly lacklustre week’
Health & Biotech
National biotech summit shows off a wealth of healthcare and medical innovation
Health & Biotech
ASX Health Stocks: Microba completes autoimmune disease discovery program with NYSE-listed Ginkgo
Health & Biotech
ASX Health Stocks: Imagion and Microba’s positive Phase 1 results; and LGP’s first mover advantage in France
Health & Biotech
ASX Health Stocks: Nova Eye catches a break as US Medicare reimbursement decision deferred until March
News
Top 10 at 11: This morning is all about lithium, graphite and the fight against Glioblastoma
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX plunges as broad based losses follow perfect storm of fears
Health & Biotech
ASX Health Stocks: Telix tumbles 17pc, Emyria to import MDMA after approval in Canada
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as Volpara records third quarter of positive cashflow
Health & Biotech
ASX Health Stocks: Ramsay Healthcare up 7pc as its looks to sell joint Asian Venture
Health & Biotech
ScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall as CSL faces FX headwinds
Health & Biotech
ASX Health Stocks: AFT Pharma wins crucial US FDA approval for Maxigesic pain tablets
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but cap raises show money flowing into sector
Health & Biotech
ASX Health Stocks: Imagion jumps 20pc after delivering positive Phase 1 results
